Transforming Clinical Trials: Direct-to-Patient Supply Models
Traditionally, the clinical supply chain’s goal has been to ensure that supplies are available for use at clinical trial sites and buffered with levels that account for normal trial variances. However, modern trial designs are changing the requirements for clinical supply chains.
This white paper explores innovative direct-to-patient (DTP) supply models that are revolutionizing clinical trial design and execution, outlining two primary DTP approaches: Depot-to-Site-to-Patient and Depot-to-Patient, helping sponsors determine which model best suits their specific trial requirements.
The paper also offers critical variables sponsors must consider when implementing DTP strategies, including:- Patient visit schedules
- Medication administration requirements
- Storage conditions
- Accountability processes
Through a real-world case study, readers gain practical insights into successfully transitioning a complex Phase 2 trial with temperature-controlled, IV-administered investigational product to a hybrid model mid-study.
Download the paper below, and visit our RTSM solution page to learn how integrated DTP functionality can enhance your programs.
